image: Amanda Woerman is an assistant professor of biology at UMass Amherst. see After Credit: UMass Amherst A scientist at the University of Massachusetts Amherst has discovered that a mutation in the misfolded protein that causes Parkinson’s disease offers protection against another deadly neurodegenerative disease – multiple system atrophy (MSA), which is caused by the …
Summary: In addition to previous research on the link between the gut-brain axis and Parkinson’s disease, researchers have found that the gut microbiome is involved in multiple pathways in the pathogenesis of Parkinson’s disease. Source: University of Alabama at Birmingham New research from the University of Alabama at Birmingham indicates that the gut microbiome is …
Gut microbiome at center of Parkinson’s disease pathogenesis – Neuroscience News Read More »
The study, using the relatively new field of metagenomics, demonstrated an imbalance in the gut microbiome of patients with Parkinson’s disease. Haydeh Payami, Ph.D.New research from the University of Alabama at Birmingham indicates that the gut microbiome is involved in multiple pathways in the pathogenesis of Parkinson’s disease. The results, published in Nature Communications, show …
According to a new study, variations in small repetitive DNA sequences called short tandem repeats (STRs) are associated with an altered risk of developing Parkinson’s disease. “We demonstrate for the first time that these complex repeat regions actually influence a person’s risk of disease and reduce understanding of all of the complex genetic factors that …
Transposable elements, a common feature of the so-called “dark genome”, are associated with clinical differences in the progression of Parkinson’s disease in different people, according to a new study. “Our main finding is that the presence or absence of [transposable elements] changes the progression trajectory of [Parkinson’s]and we have provided supporting clinical, imaging and biochemical …
The research could lead to new strategies for the treatment of Parkinson’s disease. A recent study reveals how Parkinson’s disease spreads throughout the brain. According to a recent study by scientists at Weill Cornell Medicine, aggregates of the protein alpha-synuclein spread through the brains of patients with Parkinson’s disease through a process of ejection of …
A new discovery could solve a mystery of Parkinson’s disease Read More »
Testing whether a new drug has an impact on the progression of Parkinson’s disease takes years, in part because the disease often progresses very slowly. Many patients with Parkinson’s disease experience no worsening of their symptoms during a typical clinical trial, even without treatment. Now Scripps Research scientists have developed a tool that analyzes genetic …
